Shanghai Begin Period Cash Flow from 2010 to 2024

688217 Stock   21.07  0.83  3.79%   
Shanghai Rightongene's Begin Period Cash Flow is decreasing over the years with very volatile fluctuation. Begin Period Cash Flow is expected to dwindle to about 164.5 M. Begin Period Cash Flow is the amount of cash Shanghai Rightongene Biotechnology has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
2010-12-31
Previous Quarter
203.2 M
Current Value
164.5 M
Quarterly Volatility
18.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Shanghai Rightongene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shanghai Rightongene's main balance sheet or income statement drivers, such as Net Interest Income of 2.2 M, Interest Income of 2.8 M or Interest Expense of 464.7 K, as well as many indicators such as . Shanghai financial statements analysis is a perfect complement when working with Shanghai Rightongene Valuation or Volatility modules.
  
This module can also supplement various Shanghai Rightongene Technical models . Check out the analysis of Shanghai Rightongene Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

Shanghai Rightongene financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Rightongene security.